VSEE HEALTH INC (VSEE)
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
$0.02+3.58%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · VSEE
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -84.7% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and has erratic recent earnings surprises. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 22 industry peers · Company calendar date is not available
VSEE — officer change
Dated 2026-08-31
Director — Scott Metzger: A director resigned from the board and compensation committee without any stated disagreement, representing a standard board departure.
Why it matters: New leadership may shift M&A strategy. This impacts growth and operational focus.
Watch forManagement announces new M&A deals or strategies under the new CEO.
Also watch forNo major M&A activity is expected in the next quarter.
Why it matters: The new CEO may change key strategies that affect performance and investor confidence.
Watch forDr. Aisiku announces a new strategic plan or initiatives within three months.
Also watch forThe new CEO has not shared a clear plan or goals.
Why it matters: Getting financing could help with cash flow and daily operations.
Supportive ifVSee Health confirms the successful completion of the ClearThink financing.
Worry ifIf financing fails or is late, cash flow will suffer.
Why it matters: These financings might give the money needed for growth or stability.
Supportive ifVSee shares news of successful use of funds from Labrys or ClearThink financing.
Worry ifThere are no good updates on how funds are used or any improvements.
Why it matters: Changes in leaders can change how a company moves forward. They can also affect how investors feel.
Worry ifVSee appoints a new CEO with a strong track record and stability in leadership.
Less concerning ifMore leaders leaving or issues in leadership roles.
Why it matters: M&A can drive growth. Successful integration can improve financial performance.
Supportive ifThe recent acquisition is going well. It is helping to increase revenue and cut costs.
Worry ifThe acquisition is not going well. It is hurting operating income.
Why it matters: A new CEO can change company strategy. This could affect growth and operations.
Watch forPositive comments from the new CEO about future growth plans or M&A activity.
Also watch forOperating income is still negative. There is no clear plan for the future.
Why it matters: New leaders can change company plans and how it works.
Worry ifNo more leaders leaving or issues in the team.
Less concerning ifMore executive changes or problems in the leadership team.
Why it matters: Successful M&A can strengthen VSee's market position and financial health.
Supportive ifVSee completes more M&A deals that improve its services.
Worry ifVSee fails to close any new M&A deals by the end of Q3 2026.
Why it matters: Compliance with Nasdaq rules is critical for VSee Health's listing. It affects investor confidence and capital access.
Worry ifVSee Health confirmed it meets Nasdaq listing rules.
Less concerning ifThere are more notices of non-compliance or delisting from Nasdaq.
Why it matters: New purchases could change how the company makes money and its costs.
Watch forFinancial reports show more money or lower costs from recent deals.
Also watch forReports show no big changes in revenue or higher costs from the purchases.
Why it matters: New M&A deals can signal growth and strategic direction. They may enhance VSee's market position.
Supportive ifA new important agreement related to M&A was announced.
Worry ifNo new M&A announcements in the next quarter.
Why it matters: Higher operating income means better cost control. It also suggests more profits in the future.
Supportive ifOperating income improves to less than -$2.5M in the next quarter.
Worry ifOperating income worsens or remains at -$2.7M or worse.
Why it matters: The sale impacts VSee Health's balance sheet and future operations. It shows how well management handles M&A.
Supportive ifThe sale of VSee Lab is finalized and announced to the public.
Worry ifThe sale does not close as planned or faces significant delays.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$408 on $10,000 · ±4.1% | How much price usually moves either way. |
| Bad day | $1,473 loss on $10,000 · 14.7% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,891 loss on $10,000 · 98.9% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.